- Home
- GRO vs VNRX Comparison
GRO vs VNRX Comparison
Compare GRO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRO
- VNRX
- Stock Information
- Founded
- GRO 2006
- VNRX N/A
- Country
- GRO Canada
- VNRX United States
- Employees
- GRO N/A
- VNRX N/A
- Industry
- GRO
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GRO
- VNRX Health Care
- Exchange
- GRO NYSE
- VNRX Nasdaq
- Market Cap
- GRO 51.9M
- VNRX 52.4M
- IPO Year
- GRO 2024
- VNRX N/A
- Fundamental
- Price
- GRO $1.51
- VNRX $0.80
- Analyst Decision
- GRO Strong Buy
- VNRX Strong Buy
- Analyst Count
- GRO 1
- VNRX 5
- Target Price
- GRO $5.50
- VNRX $3.88
- AVG Volume (30 Days)
- GRO 192.1K
- VNRX 308.2K
- Earning Date
- GRO 08-03-2025
- VNRX 08-13-2025
- Dividend Yield
- GRO N/A
- VNRX N/A
- EPS Growth
- GRO N/A
- VNRX N/A
- EPS
- GRO N/A
- VNRX N/A
- Revenue
- GRO N/A
- VNRX $1,308,361.00
- Revenue This Year
- GRO N/A
- VNRX $563.72
- Revenue Next Year
- GRO N/A
- VNRX $160.43
- P/E Ratio
- GRO N/A
- VNRX N/A
- Revenue Growth
- GRO N/A
- VNRX 64.16
- 52 Week Low
- GRO $1.25
- VNRX $0.40
- 52 Week High
- GRO $15.00
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- GRO N/A
- VNRX 75.61
- Support Level
- GRO N/A
- VNRX $0.40
- Resistance Level
- GRO N/A
- VNRX $0.75
- Average True Range (ATR)
- GRO 0.00
- VNRX 0.08
- MACD
- GRO 0.00
- VNRX 0.02
- Stochastic Oscillator
- GRO 0.00
- VNRX 69.33
About GRO BRAZIL POTASH CORP
Brazil Potash Corp is a mineral exploration and development company with a potash mining project located in the state of Amazonas, Brazil. The company's technical operations are based in Autazes, Amazonas, Brazil, and Belo Horizonte, Minas Gerais, Brazil. The operating activities of the company include focusing on the extraction and processing of potash ore from the underground mine of the Autazes Project and selling and distributing the processed potash in Brazil.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.